144 related articles for article (PubMed ID: 24972189)
21. Biological significance of KRAS mutant allele expression in ovarian endometriosis.
Yachida N; Yoshihara K; Suda K; Nakaoka H; Ueda H; Sugino K; Yamaguchi M; Mori Y; Yamawaki K; Tamura R; Ishiguro T; Kase H; Motoyama T; Enomoto T
Cancer Sci; 2021 May; 112(5):2020-2032. PubMed ID: 33675098
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor receptor 2 expression may be involved in transformation of ovarian endometrioma to clear cell carcinoma of the ovary.
Taniguchi F; Itamochi H; Harada T; Terakawa N
Int J Gynecol Cancer; 2013 Jun; 23(5):791-6. PubMed ID: 23640291
[TBL] [Abstract][Full Text] [Related]
23. [Malignant transformation of ovarian endometriosis: a clinicopathologic analysis of 49 cases].
Shen YM; Wu XL; Xu L; Huang Q; Yu N; Yao XY; Xie YP
Ai Zheng; 2008 Oct; 27(10):1106-10. PubMed ID: 18851793
[TBL] [Abstract][Full Text] [Related]
24. Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review.
Mikhaleva LM; Davydov AI; Patsap OI; Mikhaylenko EV; Nikolenko VN; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
Adv Ther; 2020 Jun; 37(6):2580-2603. PubMed ID: 32385745
[TBL] [Abstract][Full Text] [Related]
25. Epithelial metaplastic changes in ovarian endometriosis.
Fukunaga M; Ushigome S
Mod Pathol; 1998 Aug; 11(8):784-8. PubMed ID: 9720509
[TBL] [Abstract][Full Text] [Related]
26. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
27. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
Banz C; Ungethuem U; Kuban RJ; Diedrich K; Lengyel E; Hornung D
Fertil Steril; 2010 Sep; 94(4):1212-1217. PubMed ID: 19643405
[TBL] [Abstract][Full Text] [Related]
28. MMAC tumor supressor gene expression in ovarian endometriosis and ovarian adenocarcinoma.
Cirpan T; Aygul S; Terek MC; Kazandi M; Dikmen Y; Zekioglu O; Sagol S
Eur J Gynaecol Oncol; 2007; 28(4):278-81. PubMed ID: 17713092
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of 25 cases of malignant transformation of endometriosis of the ovary].
Qian J; Shi Y; Chen X
Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):667-9. PubMed ID: 11218895
[TBL] [Abstract][Full Text] [Related]
30. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
31. Ovarian atypical endometriosis: its close association with malignant epithelial tumours.
Fukunaga M; Nomura K; Ishikawa E; Ushigome S
Histopathology; 1997 Mar; 30(3):249-55. PubMed ID: 9088954
[TBL] [Abstract][Full Text] [Related]
32. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
33. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
34. A case of squamous cell carcinoma arising from endometriosis of the ovary.
Hasegawa E; Nishi H; Terauchi F; Isaka K
Eur J Gynaecol Oncol; 2011; 32(5):554-6. PubMed ID: 22053674
[TBL] [Abstract][Full Text] [Related]
35. Endometriosis and ovarian cancer: clinical and molecular aspects.
Pavlidou A; Vlahos NF
Minerva Endocrinol; 2014 Sep; 39(3):155-65. PubMed ID: 25003226
[TBL] [Abstract][Full Text] [Related]
36. Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study.
Honda M; Isono W; Tsuchiya A; Saito A; Tsuchiya H; Matsuyama R; Fujimoto A; Nishii O
J Med Case Rep; 2019 Oct; 13(1):314. PubMed ID: 31639046
[TBL] [Abstract][Full Text] [Related]
37. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; Abrão MS
J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
39. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis.
Ren F; Wang DB; Li T; Chen YH; Li Y
J Ovarian Res; 2014 Jul; 7():73. PubMed ID: 25298284
[TBL] [Abstract][Full Text] [Related]
40. [Ovarian cancer and endometriosis].
Spaczyński M; Kedzia W
Ginekol Pol; 2001 May; 72(5):268-72. PubMed ID: 11526755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
